Transthyretin

Amyloid Proteins: The Beta Sheet Conformation and Disease

Volumn 2, Issue , 2008, Pages 571-588

  Damas, Ana Margarida ^a   Saraiva, Maria João ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b NONE

Author keywords

Amyloid diseases; Amyloidosis; Inhibitors; Ligand binding; Transthyretin

Indexed keywords

EID: 84889295460     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619344.ch21     Document Type: Chapter

References (97)

1. Wallace, M.R., Naylor, S. L., Kluve-Beckerman, B., Long, G. L., McDonald, L., Shows, T. B. and Benson, M.D. Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun 1985, 129, 753-758.
2. Mita, S., Maeda, S., Shimada, K. and Araki, S. Cloning and sequence analysis of cDNA for human prealbumin. Biochem Biophys Res Commun 1984, 124, 558-564.
3. Whitehead, A. S., Skinner, M., Bruns, G. A., Costello, W., Edge, M.D., Cohen, A. S. and Sipe, J.D. Cloning of human prealbumin complementary DNA. Localization of the gene to chromosome 18 and detection of a variant prealbumin allele in a family with familial amyloid polyneuropathy. Mol Biol Med 1984, 2, 411-423.
4. Blake, C. C., Swan, I. D., Rerat, C., Berthou, J., Laurent, A. and Rerat, B. An Xray study of the subunit structure of prealbumin. J Mol Biol 1971, 61, 217-224.
5. Blake, C. C., Geisow, M. J., Oatley, S. J., Rerat, B. and Rerat, C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 1978, 121, 339-356.
6. Andrade, C. A peculiar form of peripheral neuropathy: a typical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952, 75, 408-427.
7. Costa, P. P., Figueira, A. S. and Bravo, F. R. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978, 75, 4499-4503.
8. Saraiva, M.J., Costa, P. P. and Goodman, D.S. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type. J Lab Clin Med 1983, 102, 590-603.
9. Falls, H.F., Jackson, J., Carey, J. H., Rukavina, J. G. and Block, W.D. Ocular manifestations of hereditary primary systemic amyloidosis. Am Arch Ophthalmol 1955, 54, 660-664.
10. Saraiva, M.J. Transthyretin mutations in familial amyloidotic polyneuropathy. Hot Thyroidol 2004, 1, www.hotthyroidology.-com.
11. Westermark, P., Sletten, K., Johansson, B. and Cornwell III, G.G. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990, 87, 2843-2845.
12. Brito, R.M.M., Damas, A.M. and Saraiva, M.J. Amyloid formation by transthyretin: from protein stability to protein aggregation. Curr Med Chem-Immunol Endocr Metab Ag 2003, 3, 349-360.
13. Hamilton, J. A. and Benson, M.D. Transthyretin: a review from a structural perspective. Cell Mol Life Sci 2001, 58, 1491-1521.
14. Damas, A.M. and Saraiva, M. J. Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies. J Struct Biol 2000, 130, 290-299.
15. Schwarzman, A. L., Gregori, L., Vitek, M.P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J., et al. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci USA 1994, 91, 8368-8372.
16. Schwarzman, A. L., Tsiper, M., Wente, H., Wang, A., Vitek, M.P., Vasiliev, V. and Goldgaber, D. Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. Amyloid: J Protein Folding 2004, 11, 1-9.
17. Sparkes, R. S., Sasaki, H., Mohandas, T., Yoshioka, K., Klisak, I., Sakaki, Y., Heinzmann, C. and Simon, M.I. Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1. Hum Genet 1987, 75, 151-154.
18. Sasaki, H., Yoshioka, N., Takagi, Y. and Sakaki, Y. Structure of the chromosomal gene for human serum prealbumin. Gene 1985, 37, 191-197.
19. Soares, M., Centola, M., Chae, J., Saraiva, M.J. and Kastner, D.L. Human transthyretin intronic open reading frames are not independently expressed "in vivo" or part of functional transcripts. Biochem Biophys Acta 2003, 1626, 65-74.
20. Costa, R. H., Van Dyke, T. A., Yan, C., Kuo, F. and Darnell, J. E. Jr. Similarities in transthyretin gene expression and differences in transcription factors: liver and yolk sac compared to choroid plexus. Proc Natl Acad Sci USA 1990, 87, 6589-6593.
21. Benvenga, S., Lapa, D. and Trimarchi, F. Thyroxine binding to members and nonmembers of the serine protease inhibitor family. J Endocrinol Invest 2002, 25, 32-38.
22. Schreiber, G. and Richardson, S. J. The evolution of gene expression. Structure and function of transthyretin. Comp Biochem Physiol 1997, 116B, 137-160.
23. Palha, J. A., Episkopou, V., Maeda, S., Shimada, K., Gottesman, M.E. and Saraiva, M.J. Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994, 269, 33135-33139.
24. Weisner, B. and Kauerz, U. The influence of the choroid-plexus on the concentration of prealbumin in CSF. J Neurol Sci 1983, 61, 27-35.
25. Palha, J. A. Transthyretin as a thyroid hormone carrier: function revisited. Clin Chem Lab Med 2002, 40, 1292-1300.
26. Bui, B.V., Armitage, J. A., Fletcher, E. L., Richardson, S. J., Schreiber, G. and Vingrys, A. J. Retinal anatomy and function of the transthyretin null mouse. Exp Eye Res 2001, 73, 651-659.
27. Liz, M.A., Faro, C. J., Saraiva, M.J. and Sousa, M.M. Transthyretin, a new cryptic protease. J Biol Chem 2004, 279, 21431-21438.
28. Kanda, Y., Goodman, W. S., Canfield, R. E. and Morgan, F. J. The amino acid sequence of human plasma prealbumin. J Biol Chem 1974, 249, 6796-6805.
29. De La Paz, P., Burridge, J. M., Oatley, S. J. and Blake, C. C. F. Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin. In The Design of Drugs to Macromolecular Targets, Beddell, C. R. (ed.). Wiley, New York, 1992, pp. 120-157.
30. Wojtczak, A., Cody, V., Luft, J.R. and Pangborn W. Structures of human transthyretin complexed with thyroxine at 2.0 Å resolution and 3́,5́-dinitro-N-acetyl-l-thyronine at 2.2 Å resolution. Acta Crystallogr D 1996, 52, 758-765.
31. Monaco, H.L., Rizzi, M. and Coda, A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 1995, 268, 11039-10410.
32. Naylor, H.M. and Newcomer, M.E. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 1999, 38, 2647-2653.
33. Eneqvist, T. and Sauer-Eriksson, A. E. Structural distribution of mutations associated with familial amyloidotic polyneuropathy in human transthyretin. Amyloid: J Protein Folding 2001, 8, 149-168.
34. Hornberg, A., Eneqvist, T., Olofsson, A., Lundgren, E. and Sauer-Eriksson, A. E. A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J Mol Biol 2000, 302, 649-669.
35. Sebastião, M.P., Saraiva, M.J. and Damas, A.M. The crystal structure of amyloidogenic Leu55-Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem 1998, 273, 24715-24722.
36. Sebastião, M.P., Lamzin, V., Saraiva, M.J. and Damas, A.M. Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution. J Mol Biol 2001, 306, 733-744.
37. Wojtczak, A. Crystal structure of rat transthyretin at 2.5 Å resolution: first report on a unique tetrameric structure. Acta Biochim Pol 1997, 44, 505-517.
38. Sunde, M., Richardson, S. J., Chang, L., Pettersson, T. M., Schreiber, G. and Blake, C. C. F. The crystal structure of transthyretin from chicken. Eur J Biochem 1996, 236, 491-499.
39. Folli, C., Pasquato, N., Ramazzina, I., Battistutta, R., Zanotti, G. and Berni, R. Distinctive binding and structural properties of piscine transthyretin. FEBS Lett 2003, 555, 279-284.
40. Eneqvist, T., Lundberg, E., Karlsson, A., Huang, S., Santos, C. R. A., Power, D.M. and Sauer-Eriksson, E. High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine. J Biol Chem 2004, 279, 26411-26416.
41. Hammarstrom, P., Wiseman, R. L, Powers, E.T. and Kelly, J.W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 2003, 299, 713-716.
42. Alves, I., Hays, M.T. and Saraiva, M.J. Comparative stability and clearance of [Met30] transthyretin and [Met119] transthyretin. Eur J Biochem 1997, 249, 662-668.
43. Almeida, M.R., Alves, I. L., Terazaki, H., Ando, Y. and Saraiva, M.J. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M. Biochem Biophys Res Commun 2000, 270, 1024-1028.
44. Serpell, L. C., Goldsteins, G., Dacklin, I., Lundgren, E. and Blake, C. F. The "edge strand" hypothesis: prediction and test of a mutational "hot-spot" on the transthyretin molecule associated with FAP amyloidogenesis. Amyloid: Int J Exp Clin Invest 1996, 3, 75-85.
45. Terry, C., Damas, A. M., Oliveira, P., Saraiva, M.J., Alves, I., Costa, P., Sakaki, Y. and Blake, C. Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 1993, 12, 735-741.
46. Schormann, N., Murrel, J. R. and Benson, M.D. Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation. Amyloid: Int J Exp Clin Invest 1998, 5, 175-187.
47. Inouye, H., Domingues, F. S., Damas, A. M., Saraiva, M.J., Lundgren, E., Sandgren, O. and Kirschner, D. Analysis of X-ray diffraction patterns from amyloid of biopsied vitreous tumor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: axially arrayed TTR monomers constitute the protofilament. Amyloid: Int J Clin Invest 1998, 5, 163-174.
48. Redondo, C., Damas, A.M. and Saraiva, M.J. Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicity. Biochem J 2000, 348, 167-172.
49. Hammarstrom, P., Jiang, X., Deechongkit, S. and Kelly, J.W. Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy. Biochemistry 2001, 40, 11453-11459.
50. Quintas, A., Saraiva, M.J. and Brito, R.M.M. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution. FEBS Lett 1997, 418, 297-300.
51. Quintas, A., Saraiva, M.J. and Brito, R.M.M. The tetrameric protein transthyretin dissociates to a non-native monomer in solution. J Biol Chem 1999, 274, 32943-32949.
52. Cardoso, I., Goldsbury, C. S., Muller, S. A., Olivieri, V., Wirtz, S., Damas, A. M., Aebi, U. and Saraiva, M. J. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloidlike fibrils. J Mol Biol 2002, 317, 683-695.
53. Sebastião, M.P., Merlini, G., Saraiva, M.J. and Damas, A.M. The molecular interaction of 4́-iodo-4́-deoxydoxorubicin with Leu-55Pro transthyretin "amyloidlike" oligomer leading to disaggregation. Biochem J 2000, 351, 273-279.
54. Liu, K., Cho, H.S., Hoyt, D.W., Nguyen, T. N., Olds, P., Kelly, J.W. and Wemmer, D.E. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface. J Mol Biol 2000, 303, 555-565.
55. Liu, K., Kelly, J.W. and Wemmer, D.E. Native state hydrogen exchange study of suppressor and pathogenic variants of transthyretin. J Mol Biol 2002, 320, 821-832.
56. Liu, K., Cho, H.S., Lashuel, H.A., Kelly, J.W. and Wemmer, D.E. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat Struct Biol 2000, 7, 754-757.
57. Yang, M., Lei, M. and Huo, S. Why is Leu55-Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers. Protein Sci 2003, 12, 1222-1231.
58. Gales, L., Cardoso, I., Fayard, B., Quintanilha, A., Saraiva, M. J. and Damas, A.M. X-ray absorption spectroscopy reveals a substantial increase of sulfur oxidation in transthyretin (TTR) upon fibrillization. J Biol Chem 2003, 278, 11654-11660.
59. Lewis, W. D., Skinner, M., Simms, R.W., Jones, L. A., Cohen, A.S. and Jenkins, R. L. Orthotopic liver transplantation for familial amyloidotic polyneuropathy. Clin Transplant 1994, 8, 107-110.
60. Peterson, S. A., Klabunde, T., Lashuel, H.A., Purkey, H., Sacchettini, J. C. and Kelly, J.W. Inhibiting transthyretin conformational changes that lead to amyloid formation. Proc Natl Acad Sci USA 1998, 95, 12956-12960.
61. Oza, V. B., Petrassi, H.M., Purkey, H.E. and Kelly, J.W. Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors. Bioorg Med Chem Lett 1999, 9, 1-6.
62. Baures, P.W., Peterson, S. A. and Kelly, J.W. Discovering transthyretin amyloid fibril inhibitors by limited screening. Bioorg Med Chem 1998, 6, 1389-1401.
63. Oza, V. B., Smith, C., Raman, P., Koepf, E. K., Lashuel, H.A., Petrassi, H.M., Chiang, K. P., Powers, E.T., et al. Synthesis, structure and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors. J Med Chem 2002, 45, 321-332.
64. Klabunde, T., Petrassi, M.P., Oza, V. B., Raman, P., Kelly, J.W. and Sacchettini, J. Rational design of potent human transthyretin amyloid diseases inhibitors. Nat Struct Biol 2000, 7, 312-321.
65. Almeida, M.R., Macedo, B., Cardoso, I., Alves, I., Valencia, G., Arsequelle, G., Planas, A. and Saraiva, M.J. Effective and selective action of an iodinated diflunisal derivative in transthyretin binding and tetramer stabilization in serum from familial amyloidotic polyneuropathy patients. Biochem J 2004, 381, 351-356.
66. Merlini, G., Ascari, E., Amboli, N., Bellotti, V., Arbustini, E., Perfetti, V., Ferrari, M., Zorzoli, I., et al. Interaction of the anthracycline 4́-iodo-4́-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci USA 1995, 92, 2959-2963.
67. Palha, J. A., Ballinari, D., Amboldi, N., Cardoso, I., Fernandes, R., Bellotti, V., Merlini, G. and Saraiva, M.J. 4́-Iodo-4́-deoxydoxorubicin (I-DOX) disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol 2000, 156, 1919-1925.
68. Sc in vitro. J Mol Biol 2000, 300, 1309-1322.
69. Cardoso, I., Merlini, G. and Saraiva, M.J. 4́-Iodo-4́-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing non-cytotoxic species. Screening for TTR fibril disrupters. FASEB J 2003, 17, 803-809.
70. Sousa, M.M., Cardoso, I., Fernandes, R., Guimaraes, A. and Saraiva, M.J. Deposition of transthyretin in early stages of familial Amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001, 159, 1993-2000.
71. Bucciantini, M., Calloni, G., Chiti, F., Formigli, L., Nosi, D., Dobson, C.M. and Stefani, M. Pre-fibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 2004, 279, 31374-31382.
72. Wojtczak, A., Luft, J. and Cody, V. Mechanism of molecular recognition. Structural aspects of 3,3́-diiodo-l-thyronine binding to human serum transthyretin. J Biol Chem 1992, 267, 353-357.
73. Neumann, P., Cody, V. and Wojtczak, A. Structural basis of negative cooperativity in transthyretin. Acta Biochim Pol 2001, 48, 867-875.
74. Prapunpoj, P., Richardson, S. J. and Schreiber, G. Crocodile transthyretin: structure, function and evolution. Am J Physiol Reg Integr Comp Physiol 2002, 283, R885-R896.
75. Monaco, H.L. The transthyretin-retinolbinding protein complex. Biochim Biophys Acta 2000, 1482, 65-72.
76. Sousa, M.M., Berglund, L. and Saraiva, M.J. Transthyretin in high density lipoproteins-association via apolipprotein AI. J Lipid Res 2000, 41, 58-65.
77. Sousa, M.M., Norden, A.G.W., Jacobsen, C., Willnow, T. E., Christensen, E. I., Thakker, R.V., Verroust, P. J., Moestrup, et al. Evidence for the role of megalin in renal uptake of transthyretin. J Biol Chem 2000, 275, 38176-38181.
78. Sousa, M.M. and Saraiva, M.J.M. Internalization of transthyretin: evidence for a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J Biol Chem 2001, 276, 14420-14425.
79. Sousa, M.M., Yan, S. D., Stern, D. and Saraiva, M.J. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor αB (NF-αB) activation. Lab Invest 2000, 80, 1101-1110.
80. Sousa, M.M., Du Yan, S., Fernandes, R., Guimaraes, A., Stern, D. and Saraiva, M.J. Familial amyloidotic polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 2001, 21, 7576-7586.
81. Brouwer, A. Inhibition of thyroid hormone transport in plasma of rats by polychlorinated biphenyls. Arch Toxicol Suppl 1989, 13, 440-445.
82. Lans, M.C., Damas, A., Blake, C. C. F., Saraiva, M.J., Klasson-Wehler, E. and Brouwer, A. Structural basis for the binding of hydroxylated polychlorobiphenyl (PCB) metabolites to human transthyretin. In Thyroid Hormone Binding Proteins as Novel Targets for Hydroxylated Polyhalogenated Aromatic Hydrocarbons (PHAHs): Possible Implications For Toxicity, Lans, M.C. (ed.). Landbouw Universiteit, Wageningen, 1995, pp. 93-113.
83. McKinney, J. D., Chae, K., Oatley, S. J. and Blake, C. C. F. Molecular interactions of toxic chlorinated dibenzo-p-dioxins and dibenzofurans with thyroxine binding prealbumin. J Med Chem 1985, 28, 375-381.
84. Bellotti, V., Mangione, P. and Stoppini, M. Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci 1999, 55, 977-991.
85. Terazaki, H., Ando, Y., Suhr, O., Ohlsson, P. I., Obayashi, K., Yamashita, T., Yoshimatsu, S., Suga, M., et al. Posttranslational modifications of transthyretin in plasma. Biochem Biophys Res Commun 1998, 249, 26-30.
86. Lim, A., Prokaeva, T., McComb, M.E., Connors, L. H., Skinner, M. and Costello, C. E. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis. Protein Sci 2003, 12, 1775-1785.
87. Tajiri, T., Ando, Y., Hata, K., Kamide, K., Hashimoto, M., Nakamura, M., Terazaki, H., Yamashita, T., et al. Amyloid formation in rat transthyretin: effect of oxidative stress. Clin Chim Acta 2002, 323, 129-137.
88. Lim, A., Sengupta, S., McComb, M.E., Theberge, R., Wilson, W. G., Costello, C. E. and Jacobsen, D.W. In vitro and in vivo interactions of homo cysteine with human plasma transthyretin. J Biol Chem 2003, 278, 49707-49713.
89. Suhr, O. E., Svendsen, I. H., Ohlsson, P., Lendoire, J., Trigo, P., Tashima, K., Ranløv, P. J. and Ando, Y. Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1999, 6, 187-191.
90. Zhang, Q. and Kelly, J.W. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 2003, 42, 8756-8761.
91. Jacobsson, B. In situ localization of transthyretin-mRNA in the adult human liver, choroids plexus and pancreatic islets and in endocrine tumours of the pancreas and gut. Histochemistry 1989, 91, 299-304.
92. Harms, P. J., Tu, G. F., Richardson, S. J., Aldred, A. R., Jaworowski, A. and Schreiber, G. Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates. Comp Biochem Physiol B 1991, 99, 239-249.
93. Achen, M.G., Duan, W., Pettersson, T. M., Harms, P. J., Richardson, S. J., Lawrence, M.C., Wettenhall, R. E., Aldred, A. R., et al. Transthyretin gene expression in choroid plexus first evolved in reptiles. Am J Physiol 1993, 265, R982-R989.
94. Aldred, A. R., Prapunpoj, P. and Schreiber, G. Evolution of shorter and more hydrophilic transthyretin N-termini by stepwise conversion of exon 2 into intron 1 sequences (shifting the 3́ splice site of intron 1). Eur J Biochem 1998, 252, 612.
95. Chang, L., Munro, S. L., Richardson, S. J. and Schreiber, G. Evolution of thyroid hormone binding by transthyretins in birds and mammals. Eur J Biochem 1999, 259, 534-542.
96. Richardson, S. J. The evolution of transthyretin synthesis in vertebrate liver, primitive eukaryotes and in bacteria. Clin Chem Lab Med 2002, 40, 1191-1199.
97. Eneqvist, T., Lundberg, E., Nilsson, L., Abagyan, R. and Sauer-Eriksson, A. E. The transthyretin-related protein family. Eur J Biochem 2003, 270, 518-532.